Filing Details
- Accession Number:
- 0001628280-24-052606
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-30 19:44:18
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-30 19:44:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 1600 West End Ave. Suite 1300 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-02 | 70 | $1.33 | 5,701,597 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-03 | 70 | $1.26 | 5,701,667 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-04 | 70 | $1.22 | 5,701,737 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-05 | 65 | $1.20 | 5,701,802 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-06 | 70 | $1.20 | 5,701,872 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-09 | 70 | $1.25 | 5,701,942 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-10 | 32 | $2.48 | 5,701,974 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-11 | 32 | $2.29 | 5,702,006 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-12 | 32 | $2.19 | 5,702,038 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-13 | 32 | $2.33 | 5,702,070 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-16 | 49 | $2.21 | 5,702,119 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-17 | 49 | $2.12 | 5,702,168 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-18 | 49 | $2.19 | 5,702,217 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-19 | 40 | $2.33 | 5,702,257 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-12-20 | 39 | $2.35 | 5,702,296 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
Billionaire Hedge Funds
